TY - JOUR
T1 - Oral films as breakthrough tools for oral delivery of proteins/peptides
AU - Castro, Pedro M.
AU - Fonte, Pedro
AU - Sousa, Flávia
AU - Madureira, Ana Raquel
AU - Sarmento, Bruno
AU - Pintado, Manuela E.
PY - 2015/6/11
Y1 - 2015/6/11
N2 - Therapeutic proteins and peptides demonstrate unique, peerless, pharmacological characteristics such as high specificity to receptors and superior biological mimicking of physiological mechanisms, resulting in a better therapeutic index compared to conventional chemical-derived drugs. However, proteins also present inherent bioavailability limitations. Thus, this paper proposes several effective tools to improve protein/peptide drugs stability, permeability and pharmacokinetics with special emphasis on oral polymeric films as oral delivery platforms. Indeed, oral films present inherent characteristics that can greatly enhance biological performance of proteins and peptides and patient compliance along with other advantages that are critically discussed in this review. A rational choice of excipients addressed in and manufacture processes are also focused. In addition, possible toxicity issues to be overtaken and critical analysis regarding current market tendencies respecting oral films and protein/peptides along with future prospects are disclosed.
AB - Therapeutic proteins and peptides demonstrate unique, peerless, pharmacological characteristics such as high specificity to receptors and superior biological mimicking of physiological mechanisms, resulting in a better therapeutic index compared to conventional chemical-derived drugs. However, proteins also present inherent bioavailability limitations. Thus, this paper proposes several effective tools to improve protein/peptide drugs stability, permeability and pharmacokinetics with special emphasis on oral polymeric films as oral delivery platforms. Indeed, oral films present inherent characteristics that can greatly enhance biological performance of proteins and peptides and patient compliance along with other advantages that are critically discussed in this review. A rational choice of excipients addressed in and manufacture processes are also focused. In addition, possible toxicity issues to be overtaken and critical analysis regarding current market tendencies respecting oral films and protein/peptides along with future prospects are disclosed.
KW - Bioactive peptides
KW - Bioactive proteins
KW - Bioavailability enhancement
KW - Oral delivery
KW - Oral films
KW - Stability
UR - http://www.scopus.com/inward/record.url?scp=84930945233&partnerID=8YFLogxK
U2 - 10.1016/j.jconrel.2015.05.258
DO - 10.1016/j.jconrel.2015.05.258
M3 - Review article
C2 - 25979328
AN - SCOPUS:84930945233
SN - 0168-3659
VL - 211
SP - 63
EP - 73
JO - Journal of Controlled Release
JF - Journal of Controlled Release
ER -